{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:05:39Z","timestamp":1789380339950,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Appendiceal cancer is a rare and biologically distinct gastrointestinal malignancy characterized by marked molecular heterogeneity and a strong propensity for peritoneal dissemination. Traditional surveillance modalities, including cross-sectional imaging and serum tumor markers, often demonstrate limited sensitivity for detecting residual or recurrent peritoneal disease, creating a need for more effective biomarkers. Circulating tumor DNA (ctDNA) has emerged as a promising noninvasive tool for genomic profiling, prognostication, and disease monitoring across gastrointestinal (GI) cancers. In this review, we synthesize current evidence regarding the application of ctDNA in appendiceal malignancies. Available studies demonstrate high concordance between plasma ctDNA and tissue-based genomic profiling, while longitudinal ctDNA monitoring shows its potential for risk stratification, recurrence detection, and postoperative surveillance, with some studies suggesting improved performance compared with conventional biomarkers. However, the clinical utility of plasma ctDNA is limited by the unique biology of appendiceal cancer, particularly its tendency toward isolated peritoneal spread and pseudomyxoma peritonei (PMP), both of which are associated with reduced systemic tumor DNA shedding and frequent false negative results. We discuss the biological mechanisms underlying these limitations and highlight peritoneal tumor DNA (ptDNA) as a promising complementary biomarker capable of overcoming the peritoneal-vascular barrier through direct sampling of the local tumor microenvironment. Emerging evidence suggests that ptDNA may improve detection of occult peritoneal disease, enhance molecular characterization, and provide prognostic information beyond that obtainable from plasma-based assays alone. While liquid biopsy technologies hold substantial promise for advancing personalized management of appendiceal cancer, prospective validation studies and standardized assay approaches are needed before widespread clinical implementation.<\/jats:p>","DOI":"10.3389\/fonc.2026.1935036","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:35:51Z","timestamp":1789378551000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating tumor DNA in appendiceal malignancies: a comprehensive review of clinical applications and limitations"],"prefix":"10.3389","volume":"16","author":[{"given":"Kellyn E.","family":"McKee","sequence":"first","affiliation":[{"name":"University of Virginia School of Medicine","place":["Charlottesville, VA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Oh","sequence":"additional","affiliation":[{"name":"University of Virginia School of Medicine","place":["Charlottesville, VA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Ruff","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Virginia Health","place":["Charlottesville, VA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2022.1026","article-title":"Clinical circulating tumor DNA testing for precision oncology","volume":"55","author":"Kim","year":"2023","journal-title":"Cancer Res Treat"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194743","article-title":"Role of circulating tumor DNA in gastrointestinal cancers: Current knowledge and perspectives","volume":"13","author":"Moati","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human Malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25641","article-title":"Appendiceal cancer masked as inflammatory appendicitis in the elderly, not an uncommon presentation (Surveillance Epidemiology and End Results (SEER)-Medicare analysis)","volume":"120","author":"Siddharthan","year":"2019","journal-title":"J Surg Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294153","article-title":"Incidence trends and survival analysis of appendiceal tumors in the United States: Primarily changes in appendiceal neuroendocrine tumors","volume":"18","author":"Wang","year":"2023","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2024.02.014","article-title":"Mortality risk prediction for primary appendiceal cancer","volume":"175","author":"Winicki","year":"2024","journal-title":"Surgery"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-2474","article-title":"The landscape of circulating tumor DNA (ctDNA) in appendiceal adenocarcinoma","volume":"31","author":"White","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00531","article-title":"Multi-institutional study evaluating the role of circulating tumor DNA in the management of appendiceal cancers","volume":"8","author":"Belmont","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2018.02.007","article-title":"Peritoneal metastases from appendiceal cancer","volume":"27","author":"Votanopoulos","year":"2018","journal-title":"Surg Oncol Clin N Am"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17193275","article-title":"The genomic topography of appendiceal cancers: Our current understanding, clinical perspectives, and future directions","volume":"17","author":"Gironda","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2017160150","article-title":"Neoplasms of the appendix: Pictorial review with clinical and pathologic correlation","volume":"37","author":"Leonards","year":"2017","journal-title":"RadioGraphics"},{"key":"B12","article-title":"Appendiceal tumors","volume-title":"Statpearls","author":"Dsouza","year":"2026"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0081","article-title":"Appendiceal mucinous neoplasms: Diagnosis and management","volume":"22","author":"Shaib","year":"2017","journal-title":"Oncologist"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2019.151401","article-title":"Goblet cell tumors of the appendix: A review","volume":"43","author":"Sinno","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1642051","article-title":"Appendiceal neoplasms","volume":"31","author":"Hatch","year":"2018","journal-title":"Clin Colon Rectal Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3388","article-title":"Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer","volume":"25","author":"Tokunaga","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15143591","article-title":"Landscape of genetic mutations in appendiceal cancers","volume":"15","author":"Constantin","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0318","article-title":"Molecular characterization of appendiceal goblet cell carcinoid","volume":"19","author":"Arai","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00302","article-title":"Genomic landscape of appendiceal neoplasms","volume":"2","author":"Ang","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"418\u2013","DOI":"10.1200\/jco.2011.29.4_suppl.418","article-title":"Use of gene expression profiling to determine prognosis and therapeutic targets for patients with appendiceal carcinoma","volume":"29","author":"Kim","year":"2011","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1706174","article-title":"Application of cell-free DNA analysis to cancer treatment","volume":"379","author":"Corcoran","year":"2018","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1245\/s10434-026-19351-4","article-title":"Integrated liquid biopsy and tumor tissue genomic profiling of appendiceal cancer: cfDNA burden, mutation landscapes, and clinical outcomes","volume":"33","author":"Patel","year":"2026","journal-title":"Ann Surg Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0558","article-title":"Blood-based next-generation sequencing analysis of appendiceal cancers","volume":"25","author":"Shaib","year":"2020","journal-title":"Oncologist"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005856","article-title":"Role of tumor-informed personalized circulating tumor DNA assay in informing recurrence in patients with peritoneal metastases from colorectal and high-grade appendix cancer undergoing curative-intent surgery","volume":"278","author":"Dhiman","year":"2023","journal-title":"Ann Surg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6561-z","article-title":"Preoperative circulating tumor DNA in patients with peritoneal carcinomatosis is an independent predictor of progression-free survival","volume":"25","author":"Baumgartner","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08331-x","article-title":"Prognostic utility of pre- and postoperative circulating tumor DNA liquid biopsies in patients with peritoneal metastases","volume":"27","author":"Baumgartner","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061738","article-title":"Circulating tumor DNA as a preoperative marker of recurrence in patients with peritoneal metastases of colorectal cancer: A clinical feasibility study","volume":"9","author":"Beagan","year":"2020","journal-title":"J Clin Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231220607","article-title":"Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I\u2013IV colorectal cancer","volume":"16","author":"Fan","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091461","article-title":"Liquid biopsy in peritoneal carcinomatosis from colorectal cancer: Current evidence and future perspectives","volume":"17","author":"Martelli","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.14744\/nci.2023.50374","article-title":"Pseudomyxoma peritonei: The struggle of a lifetime and the hope of a cure - a rare diagnosis with review of the literature","volume":"11","author":"Askar","year":"2024","journal-title":"North Clin Istanb"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1200\/PO.22.00572","article-title":"Highly sensitive circulating tumor DNA assay aids clinical management of radiographically occult isolated peritoneal metastases in patients with GI cancer","volume":"7","author":"Singh","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1245\/s10434-024-16366-7","article-title":"Predictors of recurrence in nonmetastatic appendiceal epithelial cancers: An updated single-center experience over 25 years","volume":"32","author":"Aguirre","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12399-y","article-title":"Circulating tumor DNA is unreliable to detect somatic gene alterations in gastrointestinal peritoneal carcinomatosis","volume":"30","author":"Sullivan","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108395","article-title":"Undetectable circulating tumor DNA confirms the inability of pseudomyxoma peritonei to systemic dissemination","volume":"50","author":"Villarejo Campos","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2026.111873","article-title":"Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritonei","volume":"52","author":"Torgunrud","year":"2026","journal-title":"Eur J Surg Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/cjp2.207","article-title":"Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid","volume":"7","author":"van\u2019t Erve","year":"2021","journal-title":"J Pathology: Clin Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02424-6","article-title":"The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological Malignancies: A systematic review","volume":"129","author":"Allan","year":"2023","journal-title":"Br J Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.712754","article-title":"Targeted sequencing of ascites and peritoneal washing fluid of patients with gastrointestinal cancers and their clinical applications and limitations","volume":"11","author":"Bae","year":"2021","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13148-023-01479-9","article-title":"Peritoneal cell-free DNA as a sensitive biomarker for detection of peritoneal metastasis in colorectal cancer: A prospective diagnostic study: A prospective diagnostic study","volume":"15","author":"Yuan","year":"2023","journal-title":"Clin Epigenet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08832-9","article-title":"Peritoneal cell-free tumor DNA as biomarker for peritoneal surface Malignancies","volume":"27","author":"Leick","year":"2020","journal-title":"Ann Surg Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1935036\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:35:52Z","timestamp":1789378552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1935036\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":40,"alternative-id":["10.3389\/fonc.2026.1935036"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1935036","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"article-number":"1935036"}}